Treatment of the Uterine Cervical Cancer

Abstract

Objective To assess outcome of treatment of cervical cancer stage Ilb by various modalities.

Subjects Three hundred and eighty-five patients of stage Ilb in total 1,026 cases of carcinoma of the uterine cervix with various stages treated at National Cancer Institute from 1977-1980.

Main outcome measures Mean survival time, 5-year survival rate.

Results One thousand and twenty-six cases of carcinoma of the uterine cervix with various stages treated at National Cancer Institute from 1977-1980 were reviewed. There were 248 (24.2%) stage 0, 73 (7.1%) stage la, 27 (2.6%) stage Ib, 385 (37.6%) stage Ilb, 217 (21.2%) stage III and 76 (7.4%) stage IV. The majority of the cell types were squamous cell which constituted of 868 cases (84.6%). The other cell types were 95 (9.3%) of adenocarcinoma, 32 (3.1%) of adenosquamous and 31 (3.0%) of undifferentiated cell type. The mean age of patients by stages were 39.96, 41.34, 46.63, 46.70, 51.16 and 48.71 years for stage o, la, lb, IIb, III and IV respectively. The modes of treatment were either single or combination of surgery, radiation therapy and chemotherapy according to the stage of the disease. The results of various methods of treatment and status at last contact were analyzed and found 296 (28.8%) deaths, 569 (86.5%) cases were alive with no evidence of disease while 89 (13.5%) cases were alive with residual lesions. The remainder 72 cases (7%) were lost to follow up. Since the high prevalence of stage || cervical carcinoma, this analysis was emphasized